Evidence map›Paper›PMID 21685264›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2011

Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.

Roselle Gélinas, Julie Thompson-Legault, Bertrand Bouchard, Caroline Daneault, Asmaa Mansour, Marc-Antoine Gillis, Guy Charron, Victor Gavino, François Labarthe, Christine Des Rosiers

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Acute arrhythmias in a long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency mouse model.American journal of physiology. Heart and circulatory physiology · 2026
    Article
  2. Review
  3. A review of fatty acid oxidation disorder mouse models.Molecular genetics and metabolism · 2024
    Review
  4. Review
  5. Article
  6. Reactivation of PPARActa pharmaceutica Sinica. B · 2023
    Article
  7. Article
  8. Guidelines for assessment of cardiac electrophysiology and arrhythmias in small animals.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Complex QT/RR Relationship in Mice.Scientific reports · 2016
    Article
  17. Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  18. Article
  19. Article
  20. Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.American journal of physiology. Heart and circulatory physiology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Roselle GélinasDepartment of Nutrition, Université de Montréal, Montreal, Quebec, Canada.
Julie Thompson-Legault
Bertrand Bouchard
Caroline Daneault
Asmaa Mansour
Marc-Antoine Gillis
Guy Charron
Victor Gavino
François Labarthe
Christine Des Rosiers
Montreal Heart Institute · CAUniversité de Montréal · CAUniversité de Tours · FR

Funding

Nutritional Treatment of Fat Oxidation Defect in MiceR01DK069752 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI BRUNENGRABER, HENRI · 2005 to 2009
$2.0M
Canadian Institutes of Health Research 9575NIDDK NIH HHS R01-DK-069752
6 · The paper itself

Abstract

Patients with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency frequently present cardiomyopathy and heartbeat disorders. However, the underlying factors, which may be of cardiac or extra cardiac origins, remain to be elucidated. In this study, we tested for metabolic and functional alterations in the heart from 3- and 7-mo-old VLCAD null mice and their littermate counterparts, using validated experimental paradigms, namely, 1) ex vivo perfusion in working mode, with concomitant evaluation of myocardial contractility and metabolic fluxes using (13)C-labeled substrates under various conditions; as well as 2) in vivo targeted lipidomics, gene expression analysis as well as electrocardiogram monitoring by telemetry in mice fed various diets. Unexpectedly, when perfused ex vivo, working VLCAD null mouse hearts maintained values similar to those of the controls for functional parameters and for the contribution of exogenous palmitate to β-oxidation (energy production), even at high palmitate concentration (1 mM) and increased energy demand (with 1 μM epinephrine) or after fasting. However, in vivo, these hearts displayed a prolonged rate-corrected QT (QTc) interval under all conditions examined, as well as the following lipid alterations: 1) age- and condition-dependent accumulation of triglycerides, and 2) 20% lower docosahexaenoic acid (an omega-3 polyunsaturated fatty acid) in membrane phospholipids. The latter was independent of liver but affected by feeding a diet enriched in saturated fat (exacerbated) or fish oil (attenuated). Our finding of a longer QTc interval in VLCAD null mice appears to be most relevant given that such condition increases the risk of sudden cardiac death.

Indexed as

Acyl-CoA Dehydrogenase, Long-ChainAge FactorsAgingAnalysis of VarianceAnimalsCongenital Bone Marrow Failure SyndromesDisease Models, AnimalDocosahexaenoic AcidsElectrocardiography, AmbulatoryFish OilsHeart Conduction SystemLipid MetabolismLipid Metabolism, Inborn ErrorsLiverLong QT SyndromeMaleAcyl-CoA Dehydrogenase, Long-ChainDocosahexaenoic AcidsFish OilsPalmitic AcidTriglycerides

Identifiers

PMID21685264
PMCPMC3191095
OpenAlexW2015198104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.